The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Huntington's Disease Therapeutics-Global Market Insights and Sales Trends 2025
Synopsis
Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease.
The global Huntington's Disease Therapeutics market size is expected to reach US$ 1433.7 million by 2029, growing at a CAGR of 29.8% from 2023 to 2029. The market is mainly driven by the significant applications of Huntington's Disease Therapeutics in various end use industries. The expanding demands from the Hospitals, Clinics and Diagnostic Centers,, are propelling Huntington's Disease Therapeutics market. Antidopaminergics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Anticonvulsants segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Huntington's Disease Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Huntington's Disease Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Huntington's Disease Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Huntington's Disease Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Huntington's Disease Therapeutics covered in this report include F. Hoffmann-La Roche, H. Lundbeck, Prana Biotechnology, Teva Pharmaceutical Industries and Horizon Pharma, etc.
The global Huntington's Disease Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
F. Hoffmann-La Roche
H. Lundbeck
Prana Biotechnology
Teva Pharmaceutical Industries
Horizon Pharma
Global Huntington's Disease Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Huntington's Disease Therapeutics market, Segment by Type:
Antidopaminergics
Anticonvulsants
Antipsychotics
Antidepressants
Global Huntington's Disease Therapeutics market, by Application
Hospitals
Clinics
Diagnostic Centers
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Huntington's Disease Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Huntington's Disease Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease.
The global Huntington's Disease Therapeutics market size is expected to reach US$ 1433.7 million by 2029, growing at a CAGR of 29.8% from 2023 to 2029. The market is mainly driven by the significant applications of Huntington's Disease Therapeutics in various end use industries. The expanding demands from the Hospitals, Clinics and Diagnostic Centers,, are propelling Huntington's Disease Therapeutics market. Antidopaminergics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Anticonvulsants segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Huntington's Disease Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Huntington's Disease Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Huntington's Disease Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Huntington's Disease Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Huntington's Disease Therapeutics covered in this report include F. Hoffmann-La Roche, H. Lundbeck, Prana Biotechnology, Teva Pharmaceutical Industries and Horizon Pharma, etc.
The global Huntington's Disease Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
F. Hoffmann-La Roche
H. Lundbeck
Prana Biotechnology
Teva Pharmaceutical Industries
Horizon Pharma
Global Huntington's Disease Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Huntington's Disease Therapeutics market, Segment by Type:
Antidopaminergics
Anticonvulsants
Antipsychotics
Antidepressants
Global Huntington's Disease Therapeutics market, by Application
Hospitals
Clinics
Diagnostic Centers
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Huntington's Disease Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Huntington's Disease Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Huntington's Disease Therapeutics Market Overview
1.1 Huntington's Disease Therapeutics Product Overview
1.2 Huntington's Disease Therapeutics Market Segment by Type
1.2.1 Antidopaminergics
1.2.2 Anticonvulsants
1.2.3 Antipsychotics
1.2.4 Antidepressants
1.3 Global Huntington's Disease Therapeutics Market Size by Type
1.3.1 Global Huntington's Disease Therapeutics Market Size Overview by Type (2018-2029)
1.3.2 Global Huntington's Disease Therapeutics Historic Market Size Review by Type (2018-2023)
1.3.3 Global Huntington's Disease Therapeutics Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Huntington's Disease Therapeutics Sales Breakdown by Type (2018-2023)
1.4.2 Europe Huntington's Disease Therapeutics Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Huntington's Disease Therapeutics Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Huntington's Disease Therapeutics Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Huntington's Disease Therapeutics Sales Breakdown by Type (2018-2023)
2 Global Huntington's Disease Therapeutics Market Competition by Company
2.1 Global Top Players by Huntington's Disease Therapeutics Sales (2018-2023)
2.2 Global Top Players by Huntington's Disease Therapeutics Revenue (2018-2023)
2.3 Global Top Players by Huntington's Disease Therapeutics Price (2018-2023)
2.4 Global Top Manufacturers Huntington's Disease Therapeutics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Huntington's Disease Therapeutics Market Competitive Situation and Trends
2.5.1 Huntington's Disease Therapeutics Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Huntington's Disease Therapeutics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Huntington's Disease Therapeutics as of 2022)
2.7 Date of Key Manufacturers Enter into Huntington's Disease Therapeutics Market
2.8 Key Manufacturers Huntington's Disease Therapeutics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Huntington's Disease Therapeutics Status and Outlook by Region
3.1 Global Huntington's Disease Therapeutics Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Huntington's Disease Therapeutics Historic Market Size by Region
3.2.1 Global Huntington's Disease Therapeutics Sales in Volume by Region (2018-2023)
3.2.2 Global Huntington's Disease Therapeutics Sales in Value by Region (2018-2023)
3.2.3 Global Huntington's Disease Therapeutics Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Huntington's Disease Therapeutics Forecasted Market Size by Region
3.3.1 Global Huntington's Disease Therapeutics Sales in Volume by Region (2024-2029)
3.3.2 Global Huntington's Disease Therapeutics Sales in Value by Region (2024-2029)
3.3.3 Global Huntington's Disease Therapeutics Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Huntington's Disease Therapeutics by Application
4.1 Huntington's Disease Therapeutics Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Diagnostic Centers
4.2 Global Huntington's Disease Therapeutics Market Size by Application
4.2.1 Global Huntington's Disease Therapeutics Market Size Overview by Application (2018-2029)
4.2.2 Global Huntington's Disease Therapeutics Historic Market Size Review by Application (2018-2023)
4.2.3 Global Huntington's Disease Therapeutics Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Huntington's Disease Therapeutics Sales Breakdown by Application (2018-2023)
4.3.2 Europe Huntington's Disease Therapeutics Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Huntington's Disease Therapeutics Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Huntington's Disease Therapeutics Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Huntington's Disease Therapeutics Sales Breakdown by Application (2018-2023)
5 North America Huntington's Disease Therapeutics by Country
5.1 North America Huntington's Disease Therapeutics Historic Market Size by Country
5.1.1 North America Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Huntington's Disease Therapeutics Sales in Volume by Country (2018-2023)
5.1.3 North America Huntington's Disease Therapeutics Sales in Value by Country (2018-2023)
5.2 North America Huntington's Disease Therapeutics Forecasted Market Size by Country
5.2.1 North America Huntington's Disease Therapeutics Sales in Volume by Country (2024-2029)
5.2.2 North America Huntington's Disease Therapeutics Sales in Value by Country (2024-2029)
6 Europe Huntington's Disease Therapeutics by Country
6.1 Europe Huntington's Disease Therapeutics Historic Market Size by Country
6.1.1 Europe Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Huntington's Disease Therapeutics Sales in Volume by Country (2018-2023)
6.1.3 Europe Huntington's Disease Therapeutics Sales in Value by Country (2018-2023)
6.2 Europe Huntington's Disease Therapeutics Forecasted Market Size by Country
6.2.1 Europe Huntington's Disease Therapeutics Sales in Volume by Country (2024-2029)
6.2.2 Europe Huntington's Disease Therapeutics Sales in Value by Country (2024-2029)
7 Asia-Pacific Huntington's Disease Therapeutics by Region
7.1 Asia-Pacific Huntington's Disease Therapeutics Historic Market Size by Region
7.1.1 Asia-Pacific Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Huntington's Disease Therapeutics Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Huntington's Disease Therapeutics Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Huntington's Disease Therapeutics Forecasted Market Size by Region
7.2.1 Asia-Pacific Huntington's Disease Therapeutics Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Huntington's Disease Therapeutics Sales in Value by Region (2024-2029)
8 Latin America Huntington's Disease Therapeutics by Country
8.1 Latin America Huntington's Disease Therapeutics Historic Market Size by Country
8.1.1 Latin America Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Huntington's Disease Therapeutics Sales in Volume by Country (2018-2023)
8.1.3 Latin America Huntington's Disease Therapeutics Sales in Value by Country (2018-2023)
8.2 Latin America Huntington's Disease Therapeutics Forecasted Market Size by Country
8.2.1 Latin America Huntington's Disease Therapeutics Sales in Volume by Country (2024-2029)
8.2.2 Latin America Huntington's Disease Therapeutics Sales in Value by Country (2024-2029)
9 Middle East and Africa Huntington's Disease Therapeutics by Country
9.1 Middle East and Africa Huntington's Disease Therapeutics Historic Market Size by Country
9.1.1 Middle East and Africa Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Huntington's Disease Therapeutics Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Huntington's Disease Therapeutics Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Huntington's Disease Therapeutics Forecasted Market Size by Country
9.2.1 Middle East and Africa Huntington's Disease Therapeutics Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Huntington's Disease Therapeutics Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 F. Hoffmann-La Roche
10.1.1 F. Hoffmann-La Roche Company Information
10.1.2 F. Hoffmann-La Roche Introduction and Business Overview
10.1.3 F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.1.4 F. Hoffmann-La Roche Huntington's Disease Therapeutics Products Offered
10.1.5 F. Hoffmann-La Roche Recent Development
10.2 H. Lundbeck
10.2.1 H. Lundbeck Company Information
10.2.2 H. Lundbeck Introduction and Business Overview
10.2.3 H. Lundbeck Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.2.4 H. Lundbeck Huntington's Disease Therapeutics Products Offered
10.2.5 H. Lundbeck Recent Development
10.3 Prana Biotechnology
10.3.1 Prana Biotechnology Company Information
10.3.2 Prana Biotechnology Introduction and Business Overview
10.3.3 Prana Biotechnology Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Prana Biotechnology Huntington's Disease Therapeutics Products Offered
10.3.5 Prana Biotechnology Recent Development
10.4 Teva Pharmaceutical Industries
10.4.1 Teva Pharmaceutical Industries Company Information
10.4.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.4.3 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Products Offered
10.4.5 Teva Pharmaceutical Industries Recent Development
10.5 Horizon Pharma
10.5.1 Horizon Pharma Company Information
10.5.2 Horizon Pharma Introduction and Business Overview
10.5.3 Horizon Pharma Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Horizon Pharma Huntington's Disease Therapeutics Products Offered
10.5.5 Horizon Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Huntington's Disease Therapeutics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Huntington's Disease Therapeutics Industrial Chain Analysis
11.4 Huntington's Disease Therapeutics Market Dynamics
11.4.1 Huntington's Disease Therapeutics Industry Trends
11.4.2 Huntington's Disease Therapeutics Market Drivers
11.4.3 Huntington's Disease Therapeutics Market Challenges
11.4.4 Huntington's Disease Therapeutics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Huntington's Disease Therapeutics Distributors
12.3 Huntington's Disease Therapeutics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
